Page last updated: 2024-10-25

cifenline and Lung Diseases, Interstitial

cifenline has been researched along with Lung Diseases, Interstitial in 1 studies

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research Excerpts

ExcerptRelevanceReference
"Hypertrophic obstructive cardiomyopathy was diagnosed."1.32[Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia]. ( Hamada, M; Hara, Y; Ogimoto, A; Ohtsuka, T; Saeki, H; Saito, M; Shigematsu, Y; Yokoyama, A, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, M1
Hara, Y1
Shigematsu, Y1
Ohtsuka, T1
Saeki, H1
Ogimoto, A1
Yokoyama, A1
Hamada, M1

Other Studies

1 other study available for cifenline and Lung Diseases, Interstitial

ArticleYear
[Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2003, Volume: 40, Issue:1

    Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Female; Humans; Imidazoles; Lung Disease

2003